Normal-appearing white matter changes in multiple sclerosis: The contribution of magnetic resonance techniques

Multiple Sclerosis

Volumn 5, Issue 4, 1999, Pages 273-282

  Filippi, Massimo ^a,b   Tortorella, Carla ^a   Bozzali, Marco ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Magnetic resonance imaging; Magnetic resonance spectroscopy; Magnetization transfer imaging; Multiple sclerosis; Normal appearing white matter; T1 and T2 relaxation times

Indexed keywords

CONFERENCE PAPER; DISEASE COURSE; DISEASE SEVERITY; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; WHITE MATTER;

EID: 0032863625     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859900500414     Document Type: Conference Paper

References (86)

1. Adams CMW. (1977) Pathology of multiple sclerosis: progression of the lesion. Br Med Bull 33: 15-20.
2. Allen IV, McKeown SR. (1979) A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 41: 81-91.
3. Arstila AU, Reikkinen P, Rinne UK, Laitinen L. (1973) Studies on the pathogenesis of multiple sclerosis. Participation of lysosomes on demyelination in the central nervous system white matter outside plaques. Eur Neurol 9: 1-20.
4. Trapp BD et al. (1998) Axonal transcription in the lesions of multiple sclerosis. N Engl J Med 338: 278-285.
5. Filippi M (1998) The role of non-conventional magnetic resonance techniques in monitoring the evolution of multiple sclerosis. J Neurol Neurosurg Psychiatry 118 (Suppl: 1): 1601-1612.
6. Miller DH et al. (1996) Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 39: 6-16.
7. Filippi M et al. (1998) Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Ann Neurol 43: 449-506.
8. McDonald WI, Miller DH, Barnes D. (1992) The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol 18: 319-334.
9. Lucchinetti CF, Bruck W, Rodriguez M, Lassmann H. (1996) Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 6: 259-274.
10. Bruck W et al. (1997) Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 42: 783-793.
11. Filippi M et al. (1995) A magnetization transfer imaging study of normal appearing white matter in multiple sclerosis. Neurology 45: 478-482.
12. Loevner LA et al. (1995) Microscopic disease in normal appearing white matter on conventional MRI images in patients with multiple sclerosis: assessment with magnetization transfer measurements. Radiology 196: 511-515.
13. 1-weighted) spin-echo images. Neurology 45: 1684-1690.
14. 1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 47: 1469-1476.
15. Gass A et al. (1994) Correlation of magnetization transfer ratio with disability in multiple sclerosis. Ann Neurol 36: 62-67.
16. Ormerod IE et al. (1986) Relaxation times of apparently normal cerebral white matter in multiple sclerosis. Acta Radiol Suppl (Stockh) 396: 382-384.
17. Lancomis D, Osbakken M, Gross M. (1986) Spin-lattice relaxation (T1) times of cerebral white matter in multiple sclerosis. Magn Reson Med 3: 194-202.
18. Larsson HBW et al. (1988) In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis. Magn Reson Med 7: 43-55.
19. Miller DH et al. (1989) Precise relaxatioan time measurements of normal-appearing white matter in inflammatory central nervous system disease. Magn Reson Med 11: 331-3313.
20. Kesselring et al. (1989) Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisolone. J Neurol Neurosurg Psychiatry 52: 14-17.
21. Branin M et al. (1989) Changes within the 'normal' cerebral white matter of multiple sclerosis patients during acute attacks and during high-dose cortisone therapy assessed by means of quantitative MRI. J Neurol Neurosurg Psychiatry 52: 1355 - 1359.
22. Armspach JP et al. (1991) In vivo determination of multiexponential T2 relaxation in the brain of patients with multiple sclerosis. Magn Reson Med 9: 107-113.
23. Haughton VM et al. (1992) Quantitative MR in the diagnosis of multiple sclerosis. Magn Reson Med 26: 71-78.
24. Filippi M et al. (1994) A quantitative brain MRI study of benign and secondary progressive multiple sclerosis. J Neurol 241: 246-251.
25. Barbosa S et al. (1994) Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the 'invisible' lesion load. Magn Reson Med 12: 33-42.
26. Gasperini et al. (1996) Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: relationship to clinical parameters. J Magn Reson Imaging 6: 580-584.
27. Kidd et al. (1997) The transverse magnetization decay characteristics of longstanding lesions and normal appearing white matter in multiple sclerosis. J Neurol 244: 125-130.
28. van Hecke P et al. (1991) Human brain proton localized spectroscopy in multiple sclerosis. Magn Reson Med 18: 199-206.
29. Bruhn H et al. (1992) Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann Neurol 32: 140-150.
30. Minderhoud JM et al. (1992) In vivo phosphorus magnetic resonance spectroscopy in multiple sclerosis. Arch Neurol 49: 161-165.
31. Arnold DL et al. (1992) Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol 31: 235-241.
32. Confort-Gouny S et al. (1993) A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological disease. J Neurol Sci 118: 123-133.
33. Husted CA et al. (1994) Biochemical alteration in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1 H spectroscopic imaging. Ann Neurol 36: 157-165.
34. Davie CA et al. (1994) Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117: 49-58.
35. Roser W et al. (1995) Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter. Magn Reson Med 33: 811-817.
36. Davie CA et al. (1995) Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 118: 1583-1592.
37. Tourbach A et al. (1996) In vivo localized NMR proton spectroscopy of normal appearing white matter in patients with multiple sclerosis. J Neuroradiol 23: 49-55.
38. Kimura et al. (1996) Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: correlative findings of active versus irreversible plaque disease. Am J Neuroradiol 17: 1539-1547.
39. Matthews PM et al. (1996) Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain 119: 715-722.
40. De Stefano N et al. (1997) Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient. Neurology 49: 1138-1141.
41. Schiepers C et al. (1997) Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis. Mult Scler 3: 8-17.
42. Davie CA et al. (1997) 1H Magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal-appearing white matter in multiple sclerosis. J Neurol Neurosurg Psychiatry 63: 736-742.
43. Rooney WD et al. (1997) 1H MRSI of normal appearing white matter in multiple sclerosis. Mult Scler 3: 231-237.
44. Falini A et al. (1998) Benign versus secondary-progressive multiple sclerosis: the potential role of proton MR spectroscopy in defining the nature of disability. Am J Neuroradiol 19: 223-229.
45. Fu L et al. (1998) Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 121: 103-113.
46. Narayana PA et al. (1998) Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 43: 56-71.
47. De Stefano N et al. (1998) Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 121: 1469-1477.
48. Hiehle JF et al. (1994) Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis. Magn Res Med 32: 285-293.
49. Christiansen P et al. (1993) Increased water self-diffusion in chronic plaques and in apparently normal white matter in patients with multiple sclerosis. Acta Neurol Scand 87: 195-199.
50. Horsefield MA et al. (1996) Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance. Magn Reson Med 36: 393-400.
51. Dousset V et al. (1992) Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 182: 483-491.
52. Filippi M et al. (1996) Brain and spinal cord MR in benign multiple sclerosis: a follow-up study. J Neurol Sci 143:143-149.
53. van Buchem MA et al. (1996) Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 36: 632-636.
54. Filippi M et al. (1997) A magnetization transfer study of white matter in siblings of multiple sclerosis patients. J Neurol Sci 147: 151-153.
55. Filippi M et al. (1998) Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 43: 809-814.
56. Filippi M et al. (1998) Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium. Neurology 50: 1289-1293.
57. Rovaris M et al. (1998) Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 50: 1601-1608.
58. van Buchem MA et al. (1998) Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology 50: 1609-1617.
59. Silver NC et al. (1998) Serial magnetization transfer imaging to characterize the early evolution of new MS lesions. Neurology 51: 758-764.
60. Filippi et al. (1998) Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology in press.
61. Iannucci et al. (1998) Correlations between clinical and MRI cerebellar involvement in multiple sclerosis: assessment with T2, T1 and MT-histograms. [abstract]. Proc Soc Magn Reson Med 2: 1313.
62. Wolff SD, Balaban RS (1989) Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 10: 135-144.
63. Horsfield MA et al. (1998) Diffusion magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 64 (Suppl 1): 80-84.
64. Filippi et al. (1995) Resolution-dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosis. Ann Neurol 38: 749 -754.
65. Keiper MD et al. (1998) MR identification of white matter abnormalities in multiple sclerosis: a comparison between 1.5 T and 4 T. Am J Neuroradiol 19: 1489-1493.
66. Karlik SJ et al. (1998) Comparison of 1.5 and 4.0 Tesla magnetic resonance imaging examinations of patients with multiple sclerosis. [abstract]. 123rd Annual Meeting of the American Neurological Society, p. 69.
67. De Stefano N et al. (1998) Transient axonal dysfunction contralateral to large brain hemisferic demyelinating lesions of the type seen in multiple sclerosis. [abstract]. 123rd Annual Meeting of the American Neurological Society, p. 51.
68. Moreau T et al. (1996) Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain 119: 225-237.
69. Lycklama à Nijeholt GJ et al. (1998) Brain and spinal cord abnormalities in multiple sclerosis: correlation between MRI parameters, clinical subtypes and symptoms. Brain 121: 687-697.
70. Thompson AJ et al. (1991) Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 29: 53-62.
71. Thompson AJ et al. (1997) Primary progressive multiple sclerosis. Brain 120: 1085-1096.
72. Tortorella C et al. (1999) A magnetization transfer histogram study of normal appearing brain tissue in multiple sclerosis. Neurology (in press).
73. Dousset V et al. (1997) Magnetization transfer study of HIV encephalitis and progressive multifocal leukoence-phalopathy. Am J Neuroradiol 18: 859-901.
74. Campi A et al. (1996) Multiple white matter lesions of the brain: magnetization transfer ratios in systemic lupus erythematosus and multiple sclerosis. Int J Neuroradiol 2:134-140.
75. Wong KT et al. (1995) Magnetization transfer imaging of periventricular hyperintense white matter in the elderly. Am J Neuroradiol 16: 253-258.
76. Kato Y et al. (1997) Detection of pyramidal tract lesions in amyotrophic lateral sclerosis with magnetization-transfer measurements. Am J Neuroradiol 18: 1541-1547.
77. Ellis CM et al. (1998) A proton magnetic resonance spectroscopic study in ALS. Correlation with clinical findings. Neurology 51: 1104-1109.
78. Filippi M et al. (1999) Magnetization transfer imaging of patients with definite MS and negative conventional MRI. Neurology 52: 845-848.
79. Poser CM et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227-231.
80. Thorpe JW et al. (1996) Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain 119: 709-715.
81. Rocca MA et al. (1999) Long-term changes of magnetization transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis. AJNR Am J Neuroradiol 20: 821-827.
82. Brex PA et al. (1998) Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis. [abstract]. Mult Scler 4: 275.
83. Goodkin DE et al. (1998) PD, T1, gadolinium (Gd+) intensities, T2 and MTRs are chronically diffusely abnormal in MS brain and on monthly MRI scans are related to the appearance of new Gd+ lesions in normal appearing white matter. [abstract]. Neurology 50 (Suppl.4): A191.
84. Pike GB et al. (1998) A longitudinal study of magnetization transfer in multiple sclerosis. [abstract]. Proc Soc Magn Reson Med 1: 122.
85. Phillips M et al. (1998) Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measure of lesion burden in patients with multiple sclerosis. Am J Neuroradiol 19: 1055-1060.
86. Rovaris M et al. (1999) Brain MRI correlates of magnetization transfer imaging metrics'in patients with multiple sclerosis. J Neurol Sci (in press).